Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
JANSSEN NZ LIMITED,Esketamine,"treatment resistant depression, post augmentation",Esketamine (SPRAVATO),Recommended for decline,Community and Hospital,
